LEXIVA (ViiV Healthcare Company)
Welcome to the PulseAid listing for the LEXIVA drug offered from ViiV Healthcare Company. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ViiV Healthcare Company |
| NON-PROPRIETARY NAME: | fosamprenavir calcium |
| SUBSTANCE NAME: | FOSAMPRENAVIR CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-10-04 |
| END MARKETING DATE: | 0000-00-00 |
LEXIVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | LEXIVA from ViiV Healthcare Company |
| LABELER NAME: | ViiV Healthcare Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 700(mg/1) |
| START MARKETING DATE: | 2010-10-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49702-207_34e70053-22f6-4b0e-a192-2524aae0a1c1 |
| PRODUCT NDC: | 49702-207 |
| APPLICATION NUMBER: | NDA021548 |
Other FOSAMPRENAVIR CALCIUM Pharmaceutical Manufacturers / Labelers:
